Background: Here, we determined miR-499 involvement in the protective effect of ischemic postconditioning (IPC) against myocardial ischemia/reperfusion (I/R) injury and identified the underlying mechanisms. Methods: To investigate the cardioprotective effect of IPC-induced miR-499, rats were divided into the following five groups: sham, I/R, IPC, IPC + scramble, and IPC + antagomiR-499. Hemodynamic indexes were measured by carotid-artery intubation to assess left ventricular function . Ischemia and infarction areas of rat hearts were determined by Evans blue and triphenyltetrazolium chloride staining, and cardiomyocyte apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick-end-labeling assay. Results: IPC attenuated I/R-induced infarct size of the left ventricle (45.28 ± 5.40% vs. 23.56 ± 6.20%, P < 0.05), myocardial apoptosis, and decreased creatine kinase (1867.31 ± 242.41% vs. 990.21 ± 172.39%, P < 0.05), lactate dehydrogenase (2257.50 ± 305.11% vs. 1289.11 ± 347.28%, P < 0.05), and malondialdehyde levels (7.18 ± 1.63% vs. 4.85 ± 1.52%, P < 0.05). Additionally, left ventricular systolic pressure, +dp/dtmax, and −dp/dtmax were elevated, and left ventricular end diastolic pressure was significantly reduced in the IPC group. Furthermore, IPC-mediated cardiac protection against I/R injury was inhibited in vivo and in vitro by knockdown of cardiac miR-499, suggesting that miR-499 may participate in the protective function of IPC against I/R injury through targeting programmed cell death 4 (PDCD4). Conclusion: Our data revealed that IPC-regulated miR-499 plays an important role in IPC-mediated cardiac protection against I/R injury by targeting PDCD4.
Introduction
Despite current optimal treatment, myocardial infarction (MI) remains the leading cause of death and disability worldwide and is caused by myocardial ischemia, hypoxia due to vascular stenosis, or occlusion arising from atherosclerosis of the coronary artery [1] . The most effective therapeutic treatments against MI are the restoration of myocardial perfusion to salvage the viable myocardium, which can be accomplished through thrombolysis, percutaneous coronary intervention, and coronary artery bypass grafting [2] [3] [4] [5] . However, these reperfusion measures can induce transient and lethal injury, commonly referred to as ischemia/reperfusion (I/R) injury [6, 7] . Numerous studies demonstrated that myocardial I/R might contribute to reperfusion arrhythmia, myocardial diastolic dysfunction, and irreversibly disordered metabolism and function [8] . Therefore, cardioprotection beyond this method by timely reperfusion is needed [9] .
Ischemic postconditioning (IPC) was established by six cycles of 10-s reperfusion and 10-s left anterior descending (LAD) reocclusion, followed by 3 h of reperfusion [10] . IPC can evoke endogenous defense mechanisms that reduce infarct size, preserve endothelial function, and decrease apoptosis in order to protect the heart against myocardial ischemia [11, 12] . IPC has been successfully translated to humans with ischemic heart disease and, as an effective intervention performed at immediate reperfusion, it can be used in patients undergoing interventional reperfusion of acute MI (AMI) [13] . However, the underlying molecular mechanisms activated by IPC have not been fully clarified.
microRNAs (miRNAs) are small, double-stranded RNAs consisting of ~22 nucleotides that act as negative regulators of gene expression by inhibiting the translation of mRNA or promoting mRNA degradation by complementary base-pairing with 3′-untranslated regions (3′-UTRs) [14] . miRNAs are involved in regulating cardiac function, including heartmuscle contraction, conducting electrical signals, heart growth and morphogenesis, and the pathogenesis of MI and I/R [15] . Several miRNAs were identified in IPC studies in mice, rats, and humans [16] . miRNA-133 and miRNA-21 are upregulated and possibly involved in cardioprotection during IPC by upregulating endothelial nitric oxide synthase and heatshock protein expression [17] . The emerging role of miRNAs in IPC-induced cardioprotective signaling is promising, and suggests that it might be possible to manipulate miRNAs to achieve therapeutic effects against I/R; however, this requires further proof of cause-andeffect relationships.
miR-499 is encoded by the Myh7b gene and attenuates apoptosis induced by anoxia [18] . miR-499 also protects the myocardium against myocardial I/R injury with cardiopulmonary bypass, suggesting that mir-499 may be a potential therapeutic target in cardiac protection during open-heart surgery [19] . Wang et al. also demonstrated that miR-499 inhibits the mitochondrial apoptosis pathway and protects cardiomyocytes against H 2 O 2 -induced injury [20] . PDCD4 is an important target gene that protects cardiomyocytes from apoptosis induced by ischemia during ischemic preconditioning [21] . However, the mechanisms underlying the cardioprotective effect of IPC-regulated miR-499 remain unclear. Given the observed cardioprotective role of miR-499 in cardiac ischemic injury, we tested its possible relevance for the regulation of PDCD4 expression during IPC.
Materials and Methods

Experimental animals and design
One hundred Sprague-Dawley male rats weighing from 200 g to 250 g were randomly and equally assigned to one of five groups: sham, I/R, IPC, IPC + scramble, and IPC + antagomiR-499 (Fig. 1) . All experimental animals were obtained from the Experimental Animal Center of Fudan University, China, and all protocols were preapproved by the Experimental Animal Ethic Committee of Fudan University, China. The animals were cared for according to the Guiding Principles in the Use and Care of Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Microarray analysis of miRNA expression miRNAs were isolated from the hearts of rats in the IPC and I/R groups after a 180-min reperfusion by Trizol according to the protocol supplied by the manufacturer (Invitrogen, Carlsbad, CA, USA) for isolation of miRNA from tissues. RNA quality and quantity were assessed spectrophotometrically (Nanodrop) with 2200 TapeStation analysis (Agilent Technologies, Santa Clara, CA, USA). Each group was composed of six rats, and miRNA-expression profiling was performed using a chip containing 765 mature miRNAs (RiboArray miDETECT rat array, miRbase v21.0; RiboBio, Guangzhou, China) with three technical replicates. miRNAs labeled using the miRNA complete labeling and Hyb kit system were hybridized onto the surface of a 1 × 12k rat miRNA microarray (RiboArray Technologies; RiboBio). Each array was scanned, and statistical analysis was performed on fluorescent signal-intensity data representing miRNA expression. Standard selection criteria for visual comparison and representation of both downregulation and upregulation to identify differentially expressed miRNAs were established at P < 0.05 and |Fold Change| > 1.5. The correlation of expression profiles between the IPC and I/R groups was demonstrated by unsupervised hierarchical clustering analysis.
Knockdown of cardiac miR-499 expression in vivo using antagomiR-499
Knockdown of cardiac miR-499 expression in vivo using antagomiR-499 was performed as described previously [22] . Briefly, rats were anesthetized as described above. Eighty micrograms of synthesized antagomiR-499 or scramble as negative control diluted in 100 μL and pretreated with Lipofectamine 2000 (Invitrogen) were injected through a 26-gauge needle into the myocardium after opening the pericardium. Intramuscular injections were performed in approximately six sites prior to coronary artery occlusion (LV front wall proximal to the apex; area: ~0.8 cm 2 ). After injection, the heart was placed back into the thoracic cavity, the chest was closed with sutures, and the rat was allowed to recover. The antagomiR-499 sequence was 5′-AAACAUCACUGCAAGUCUUAA-3′, and all of the bases were 2′-O-methyl-modified (GenePharma Co. Ltd., Shanghai, China). The scramble control sequence was 5′-CAGUACUUUUGUGUAGUACAA-3′ (GenePharma Co. Ltd.). Cardiac I/R and IPC were performed in these rats, and the heart tissues were isolated for miR-499 assay after 24 h intramuscular injection.
Hemodynamic measurements
The high-fidelity micromanometer catheter (Millar Instruments, Houston, TX, USA) was conducted from the right common carotid artery to the left ventricle and connected to the biological signal-collection and -processing system through a manometer. Heart rate (HR), LV systolic pressure (LVSP), and LV end diastolic pressure (LVEDP) were recorded, and LV maximal rate of pressure rise (+dp/dtmax) and decline (−dp/dtmax) were analyzed using RM6240 (Chengdu Instrument Factory, Sichuan, China) at 3 h after reperfusion.
Detection of serum markers
At the end of reperfusion, rat arterial blood was collected, and serum was separated by centrifugation at 2500 g for 5 min at 4°C. The isoenzyme of creatine kinase (CK-MB) was determined by immunoassay (Roche Diagnostics Elecsys 2010, Basel, Switzerland). A colorimetric assay was performed according to manufacturer instructions (Roche) to detect lactate dehydrogenase (LDH). Malondialdehyde (MDA) content and superoxide dismutase (SOD) activity were measured using commercially available kits according to manufacturer protocols (Roche).
Measurement of myocardial infarct size
At 3 h after reperfusion, rats were anesthetized, and the ligature around the coronary artery was retied. Ten milliliters of 2% Evans blue dye was injected into the vena cava to stain the noninfarcted portion of the heart. The myocardial ischemic area at risk (AAR) was identified as the zone lacking blue staining. After freezing at −20°C for several hours, the heart ventricles were sectioned transversely into ~2-mm thick sections. The sections were subsequently incubated in 1% triphenyltetrazolium chloride (TTC) for 15 min at 37°C to identify the noninfarcted and infarcted areas and fixed in 10% buffered formalin. The infarcted area (INF) was displayed as the TTC-unstained area (white). We measured the areas of total left LV, INF, and AAR using Image Pro Plus software (v6.0; Media Cybernetics, Rockville, MD, USA). The percentage of the AAR/LV and INF/AAR was calculated, and infarct size was expressed as a percentage of INF/AAR.
Detection of apoptosis
Cardiomyocyte apoptosis was assessed in the heart sections by terminal deoxynucleotidyl transferasemediated dUTP nick-end-labeling (TUNEL) staining. TUNEL staining was performed using the in situ cell death detection kit (Roche) according to manufacturer protocol. The apoptosis index was determined by counting TUNEL-positive nuclei in ten random fields per section and expressed as a percentage of the total nuclei.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA from rat cardiac ventricular myocytes was isolated using Trizol reagent according to manufacturer instructions (Invitrogen) and was reverse transcribed to cDNA. The concentration and purity of the extracted total RNA was quantified by ultraviolet spectrophotometer (UV-2700; Shimadzu, Kyoto, Japan). High-quality RNA presented an A260/A280 ratio of ~1.8 to ~2.0. Total RNA was reverse transcribed in a 50-μL mixture containing 2 μg of total RNA at 25°C for 10 min, 42°C for 42 min, and 85°C for 5 min. qRT-PCR was performed in triplicate using a real-time PCR system (Applied Biosystems 7500, Applied Biosystems, Foster City, CA, USA), and U6 was used as an internal control for template normalization. Fluorescent signals were normalized to an internal reference, and the threshold cycle (Ct) was set within the exponential phase of the PCR. Relative gene expression was calculated by comparing cycle times for each target gene. The target gene Ct values were normalized by subtracting the U6 Ct value, followed by calculation of the relative expression level between groups using the 2 −ΔΔCt method as follows: relative gene expression = 2 −(ΔCt sample −ΔCt control) [17] . The primers used for amplification were as follows: miR-499, forward primer: 5′-GGG GTT AAG ACT TGC AGT G-3′; reverse primer: 5′-CAG TGC GTG TCG TGG AGT-3′; miR-21, forward primer: 5′-GGG GGG TAG CTT ATC AGA CTG -3′; reverse primer: 5′-CAG TGC GTG TCG TGG AGT -3′; miR-125a-5p, forward primer: 5′-GGG TCC GAG GTA TTC GCA CT-3′; reverse primer: 5′-TCC CTG AGA CCC TTT AAC CTG TG-3′; U6, forward primer: 5′-CTC GCT TCG GCA GCA CA-3′; reverse primer: 5′-AAC GCT TCA CGA ATT TGC GT-3′.
Luciferase assay Pdcd4 3′-UTR (PDCD4 3'-UTR) was amplified by PCR. The forward primer was 5′-CCG CTC GAG GCA CAG CAA CTC TTA CAG TCT TAG GTG TT-3′, and the reverse primer was 5′-GGC TCT AGA CTA AAG AAT CAA CAG TGT TTC ACA TGT TTT ATT TTG-3′. To produce mutated 3'-UTR variants, mutations were generated using a QuikChange II XL site-directed mutagenesis kit (Stratagene, San Diego, CA, USA), and the constructs were verified by sequencing. Wild-type and mutated 3′-UTR regions were subcloned into the pGL3 vector immediately downstream of the stop codon of the luciferase gene (Promega, Madison, WI, USA). Luciferase activity was measured using the dual-luciferase reporter assay system according to manufacturer instructions (Promega). HEK293 cells were co-transfected with 150 ng of the plasmid constructs, PDCD4-3′UTR or PDCD4-3′UTR-mut, per well using Lipofectamine 2000 (Invitrogen) and infected with plasmids expressing miR-499 or pGL3. Luciferase activity was analyzed 48 h after infection.
Isolation, culture, oligonucleotide transfection, and adenoviral infection of neonatal rat ventricular cardiomyocytes (NRVCs)
Primary NRVCs were isolated from 2-day-old Sprague-Dawley rats, and adenovirus-mediated gene transfer was performed as previously described [23] . The minced tissue and ventricular cells were dispersed by digestion with collagenase type IV (0.45 mg/mL), 0.1% trypsin, and 15 g/mL DNase I. Isolated cells were pre-plated at 37 °C for 2 h, diluted to 1 × 10 6 cells, and then seeded into six-well plates. To induce cardiomyocyte hypoxia/reoxygenation (H/R) injury, hypoxia was achieved by placing the NRVCs with a serum-free medium in a 37°C airtight chamber saturated with 5% CO 2 and 95% N 2 for 4 h. Following hypoxia treatment, the cells were reoxygenated with 5% CO 2 and 95% O 2 for 3 h in Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum. The adenovirus expressing miR-499 (Ad-miR-499) and control adenovirus expressing green fluorescent protein (GFP; Ad-GFP) were generated using the Adeno-XTM expression systems 2 kit (Clontech, Beijing, China) according to manufacturer protocols [23] .
miR-499 mimics were purchased from GenePharma Co. Ltd. The miR-499 mimic sense sequence was 5′-UUAAGACUUGCAGUGAUGUUU-3′, and the antisense sequence was 5′-AAACAUCACUGCAAGUCUUAA-3′. The miR-499 inhibitor sequence was AAACAUCACUGCAAGUCUUAA. The scramble sense sequence was UCACAACCUCCUAGAAAGAGUAGA, and the antisense sequence was UCUACUCUUUCUAGGAGGUUGUGA. The transfection was performed using Lipofectamine 2000 (Invitrogen) according to manufacturer instructions.
Western blot analysis
Proteins isolated from rat heart and cultured cardiomyocytes induced by H/R injury were determined by western blot analysis. Equal amounts of protein were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis. The proteins were then transferred onto polyvinylidene difluoride membranes, which were blocked and incubated with specific primary antibodies overnight at 4°C. A standard western blot analysis was conducted using a primary PDCD4 antibody (1:1000 dilution; Proteintech, Rosemont, IL, USA), and a GADPH antibody (1:5000 dilution; Cell Signaling, Danvers, MA, USA) was used as the loading control. The blots were visualized with enhanced chemiluminescence and quantified by densitometry.
Statistical analysis
Data are expressed as the mean ± standard error of the mean of at least three independent experiments for each cell-culture experimental group and at least five independent experiments for each animal group. The data were evaluated using the Student t test, and one-way analysis of variance was used for multiple comparisons. A P < 0.05 was considered significant.
Results
Rat cardiac miRNA expression profiles regulated by IPC
For advanced data analysis, all biological replicates were pooled and calculated to identify differentially expressed miRNAs based on the threshold of |Fold change| > 1.5 and P < 0.05. Among the 765 arrayed miRNAs, 56 were differentially expressed (23 upregulated and 33 downregulated) in the IPC rat hearts as compared with those in the I/R rat hearts (Fig. 1B) . miRNAs expressed in the rat hearts exhibiting a significant change in their expression after IPC are presented in Table 1 . Remarkably, miR-499 was one of the most upregulated miRNAs in the hearts induced by IPC, and its expression was elevated more than sevenfold as compared with levels observed in the hearts of I/R rats.
Verification of IPC-regulated miRNA-499 expression by qRT-PCR
To quantify the expression level of miR-499 in hearts under pathological conditions, we assessed miR-499 expression in the remote and infarcted areas of I/R-induced ischemic hearts by qRT-PCR. Compared with those in the remote zone, miR-499 was downregulated in the infarcted zone of the ischemic heart ( Fig. 2A) , and miR-499 expression was lower in NRVCs under anoxia conditions (Fig. 2B) . To verify IPC-regulated miRNAs identified by microarray analysis, miRNAs were isolated from rat hearts at 2, 6, and 24 h after IPC following a 180-min reperfusion. The expression of miR-499, miR-125a-5p, and miR-21 in IPC hearts was significantly upregulated at all detected time points as compared with their expression levels measured in sham-opened rat hearts (Fig. 2C) . 
Knockdown of miR-499 expression attenuates IPC-induced cardiac protection against I/R in rat hearts
To test the biological role of IPC-induced miR-499 in IPC-mediated cardiac function protection, miR-499 expression was inhibited by its antagomiR. Rats were intramyocardially injected with 80 μg miR-499 antagomiR or scramble control prior to coronary artery occlusion, and 24 h after injection, subjected to I/R or IPC. IPC-induced upregulation of cardiac miR-499 was successfully inhibited by antagomiR-499 as determined by qRT-PCR (Fig. 3) .
The myocardial AAR and infarct size were determined by TTC and Evans blue staining. Representative TTC and Evans blue-stained heart slices from treated rats in the I/R, IPC, IPC + scramble, and IPC + antagomiR-499 groups are shown in Fig. 4A . As shown in Fig. 4B , there was no difference in AAR/LV among the I/R, IPC, IPC + scramble, and IPC + antagomiR-499 groups (P > 0.05). Compared with the I/R group, the infarct size (INF/AAR) was significantly attenuated in the IPC group (45.28 ± 5.40% vs. 23.56 ± 6.20%, P < 0.05). Compared with the IPC + scramble group, the IPC + antagomiR-499 group presented a significantly exacerbated myocardial infarct size (INF/AAR; 25.68 ± 5.20% vs. 38.50 ± 3.60%, P < 0.05), and the IPC + scramble group presented no effect on IPC-induced cardiac protection.
As shown in Table 2 , levels of serum myocardial enzymes CK-MB, LDH, and MDA increased significantly in rats from the I/R group as compared with those in rats from the sham group (P < 0.05). However, the serum levels of CK-MB, LDH, and MDA of the IPC group Table 2 . CK-MB, LDH, SOD, and MDA levels in serum of rats in sham, I/R, IPC, IPC + scramble, and IPC + antagomiR-499 groups after a 180-min reperfusion. Values are expressed as the mean ± SEM. *P < 0.05 vs. sham group; # P < 0.05 vs. I/R group, ** P < 0.05 vs. IPC+ scramble group. CK-MB, isoenzyme of creatine kinase; I/R, ischemia/reperfusion; IPC, ischemic postconditioning; LDH, lactate dehydrogenase; MDA, malondialdehyde; SOD, superoxide dismutase Table 3 . Hemodynamic assessment of left ventricular function in rats after a 180-min reperfusion. Values are expressed as the mean ± SEM.*P < 0.05 vs. sham group; # P < 0.05 vs. I/R group, ** P < 0.05 vs. IPC + scramble group. +dp/dt max, left ventricular maximal rate of pressure rise; −dp/dt max, left ventricular maximal rate of pressure decline; HR, heart rate; LVEDP, left ventricular end diastolic pressure; LVSP, left ventricular systolic pressure −dp/dtmax were elevated and LVEDP was significantly reduced in the IPC group (P < 0.05). Additionally, the IPC + antagomiR-499 group showed a remarkable reduction in LVSP, +dp/ dtmax, and −dp/dtmax, as well as an increase in LVEDP, as compared with levels observed in the IPC + scramble group (P < 0.05).
Knockdown of miR-499 expression inhibits IPC-induced anti-apoptotic effects on cardiac cells against I/R in vivo
To further confirm the mechanism of IPC-induced miR-499 in IPC-mediated cardiac protection in vivo, apoptosis was determined in rat heart sections from the I/R, IPC, IPC + scramble, and IPC + antagomiR-499 groups by TUNEL staining. Representative images of cardiomyocyte apoptosis in heart sections from rats in the I/R, IPC, IPC + scramble, and IPC + antagomiR-499 groups are shown in Fig. 5A . As shown in Fig. 5B , cardiomyocyte apoptosis markedly decreased in the rats treated with IPC as compared with that observed in the I/R group (P < 0.05). The IPC + antagomiR-499 group showed a significant increase in myocardial apoptosis as compared with that observed in the IPC + scramble group (P < 0.05), and the IPC + scramble group exhibited no difference from IPC-induced cardiac apoptosis.
The anti-apoptotic effect of miR-499 on H/R-induced cardiomyocyte injury in vitro
To demonstrate the anti-apoptotic effect of miR-499 following H/R-induced cardiomyocyte injury, a cell H/R model was established, wherein NRVC injury was induced by hypoxia for 4 h in serum-free medium, followed by reoxygenation for 3 h in normal culture medium. We transfected NRVCs with a vehicle control, scramble control, miR-499 mimics, or miR-499 inhibitor and then induced H/R injury. Transfection of miR-499 mimics or inhibitor successfully increased or decreased the miR-499 levels in NRVCs (Fig.  6A) , respectively. Furthermore, TUNEL-positive cells increased significantly following transfection of the miR-499 inhibitor in NRVCs induced by H/R injury, which was reversed by transfection of miR-499 mimics, but not by scramble control (Fig. 6B) . Representative TUNEL-stained photomicrographs of cardiomyocytes treated with vehicle control, scramble control, miR-499 inhibitor, or mimics and induced by H/R injury are shown in Fig. 6C . These results suggested that miR-499 exhibits an anti-apoptotic effect in cardiomyocytes and that knockdown of endogenous miR-499 exacerbated apoptosis of cardiomyocytes induced by H/R injury.
Validation of PDCD4 as an miR-499-target gene and involvement in anti-apoptotic effects in cardiomyocytes
To validate whether Pdcd4 is an miR-499-target gene related to miR-499-mediated anti-apoptotic effects in cardiomyocytes, NRVCs were infected with adenoviral constructs encoding GFP (Ad-GFP) or miR-499 (Ad-miR-499) as shown in Fig. 7A . miR-499 expression in NRVCs increased significantly following Ad-miR-499 infection (Fig. 7B) , and miR-499 overexpression inhibited PDCD4 protein levels in vitro (Fig. 7C, D) . PDCD4 protein levels markedly decreased in rat hearts treated with IPC as compared with those observed in the I/R group in vivo (Fig. 7E, F) . Furthermore, the IPC + antagomiR-499 group showed a significant increase in PDCD4 protein levels as compared with those observed in the IPC + scramble group (P < 0.05), and the IPC + scramble group exhibited no effects on PDCD4 protein expression in vivo (Fig. 7E, F) . Computational analysis using Targetscan (http://www.targetscan.org/ vert_71/) indicated that Pdcd4 is a potential target gene of miR-499, presenting with seven complementary base pairs (Fig. 7G) . To confirm whether Pdcd4 is a direct target of miR-499, a luciferase-reporter assay was performed to determine whether miR-499 could influence PDCD4 translation. The wild-type 3 -UTR of PDCD4 (PDCD4-3′-UTR) exhibited a low translation level in the presence of miR-499, whereas miR-499 did not affect the translation of the mutated 3′-UTR of PDCD4 (PD-CD4-3′-UTR-mut) (Fig. 7H) . 
Discussion
To our knowledge, this is the first study demonstrating that miR-499 can be regulated by IPC, which plays an important role in protecting the heart against myocardial I/R injury in rats. In this study, during the reperfusion after MI, IPC attenuated the progression of myocardial I/R injury, whereas antagomiR-499 blocked the inhibitory effect of IPC on cardiac infarct size induced by I/R injury. More importantly, antagomiR-499 treatment dramatically increased cardiac myocyte apoptosis, indicating that miR-499 effectively regulated cardiomyocyte apoptosis. Our results showed reductions in LVSP, +dp/dtmax, and −dp/dtmax, as well as increases in LVEDP, suggesting significant LV systolic and diastolic dysfunction in the I/R model. However, in the IPC group, the progression of left ventricular dysfunction was prevented, suggesting that IPC improved LV systolic and diastolic function induced by I/R injury in rats. The cardiac function of rats treated with antagomiR-499 during IPC deteriorated as compared with that observed in rats from the IPC group as reported by changes in hemodynamic measurements. Additionally, our results suggested that miR-499-mediated cardioprotection might be achieved by targeting PDCD4.
miRNAs play an important role in the posttranscriptional regulation of gene expression by repressing transcription [24] [25] [26] . miRNAs also play important roles in many physiological and pathological processes in the heart, including MI, cardiac I/R injury, cardiac fibrosis, cardiac arrhythmogenesis, and heart failure [27] [28] [29] . The exact role of most IPC-regulated miRNAs in cardioprotection is unclear; however, some of these miRNAs were previously studied in the heart. Recently, several research groups reported the involvement of miRNAs in IPC [30] [31] [32] . He et al. demonstrated that IPC upregulates miR-1 and miR-133a and decreases cardiomyocyte apoptosis [16] . Myocardium-specific miR-1 and miR-133a may play an important role in IPC protection by regulating apoptosis-related genes, and miR-133a may attenuate cardiomyocyte apoptosis by targeting CASP9 [16] . Tu et al. demonstrated that miR-21 is involved in IPC-mediated cardiac protection against I/R injury and dysfunction through the PTEN/Akt-signaling pathway in vivo [17] . In silico analysis identified that miRNA29b, -133a, and -146b fulfill the minimal temporal requirements for a potential causal involvement in cardioprotection by IPC from a pig study with reduction of infarct size by ischemic postconditioning [32] . Here, we determined that miR-499 was upregulated during IPC in a rat cardiac I/R-injury model. Additionally, administration of antagomiR-499, but not scramble treatment, silenced endogenous cardiac miR-499 levels in vivo. We also observed that IPC reduced infarct size in the rat cardiac I/R-injury model, increasing LVSP, +dp/dtmax, −dp/dtmax, and decreasing LVEDP. These results are in agreement with related conclusions that IPC exerts a protective effect against I/R injury [33] . Furthermore, administration of antagomiR-499 attenuated IPC-mediated cardiac protection against I/R injury in rat hearts. Similarly, antagomiR-499-treated hearts exhibited a significant reduction in cardiac function recovery after 3 h of reperfusion, evidenced by decreased LVSP, +dp/dtmax, and −dp/dtmax and increased LVEDP.
In this study, we revealed the expression profile of miRNAs regulated by IPC in the heart, with results indicating that multiple miRNAs were regulated by IPC (Table 1) . Individual miRNAs are functionally important as transcription factors due to their ability to regulate the expression of multiple target genes [34] . This is the first demonstration using a microarray containing 765 rat miRNAs available in miRBase version 21.0 that IPC significantly affects I/R-induced global miRNA-expression profiles. Here, we identified 56 different miRNAs (23 upregulated and 33 downregulated) that were significantly affected by subsequent postconditioning as compared with I/R, showing that these miRNAs were specifically induced by postconditioning stimuli. Remarkably, miR-499 was one of the most highly upregulated miRNAs following IPC treatment in the heart, with its expression increasing by more than sevenfold as compared with levels observed in the I/R group. Therefore, our results validated a possible causal relationship between miR-499 and the cardioprotective effect of IPC on cardiac I/R injury.
Cardiac-specific biomarkers play a critical role in early diagnosis, improving diagnostic accuracy and providing prognostic information in ischemic heart disease. Damaged cardiomyocytes release several proteins into circulation, including CK, CK-MB, cardiac troponin I, and LDH [35] . CK-MB and LDH accumulate at high concentrations in the damaged myocardium and are widely available for assessing tissue-specific changes under experimental conditions and in AMI patients undergoing percutaneous coronary intervention [35, 36] . Our results showed that, compared with the sham group, the I/R group displayed significantly increased CK-MB and LDH levels. However, compared to the I/R group, the IPC group displayed decreased CK-MB and LDH levels, indicating the cardioprotective effect of IPC on I/R injury. During IPC, miR-499 knockdown by antagomiR-499 abrogated the cardioprotective effect of IPC against I/R injury as evidenced by increased CK-MB and LDH levels. Oxidative stress is the major trigger and mechanism of myocardial I/R injury and is caused by increased generation of intracellular reactive oxygen species (ROS) [37] . ROS share a paradox with IPC, in that minor levels of I/R or ROS protect the hearts from I/R injury, whereas more profound I/R or ROS formation induces injury [7] . MDA (a ROS and an index for oxidative stress) is a critical component of NADPH oxidase and is produced through lipid peroxidation. Increased MDA levels result in the release of myocardial enzymes and their subsequent attack on structural proteins and cells [38] . Given that oxidative stress is a crucial event in I/R injury, inhibition of oxidative stress is considered a viable approach to treat I/R-induced cardiac injury. Here, IPC treatment distinctly reduced MDA content in I/R rat serum and improved the SOD concentration induced by cardiac I/R injury. However, antagomiR-499 treatment significantly increased MDA content and inhibited I/R-induced SOD levels in serum. Thus, IPC and miR-499 may play cardioprotective roles by regulating oxidative stress.
Cardiac contractile dysfunction is a consequence of both reversible and irreversible injury after I/R. We present evidence that compared with I/R group, left ventricular systolic pressure, +dp/dtmax, and −dp/dtmax were elevated, and left ventricular end diastolic pressure was significantly reduced in the IPC group. In the present study, contractile dysfunction was observed in the AR of untreated hearts, as has been reported previously [10] . Contractile dysfunction in irreversibly damaged myocardium persists. However, Short periods of coronary artery occlusion cause contractile dysfunction in the absence of infarction; this recovery of myocardial stunning takes at least 6 h [39] . Postconditioning has been shown to have salubrious effects on different tissue types within the heart (cardiomyocytes, endothelium) and to protect against various pathologic processes, including necrosis, apoptosis, contractile dysfunction, arrhythmias, and microvascular injury or "no-reflow" [40] . The present demonstrated that the IPC + antagomiR-499 group showed a remarkable reduction in LVSP, +dp/dtmax, and −dp/dtmax, as well as an increase in LVEDP, as compared with levels observed in the IPC + scramble group (Table 3) .
The extensive apoptosis and necrosis of cardiomyocytes at the earliest stage of reperfusion account for most of the clinical manifestations in myocardial I/R [41] . The inhibition of cardiac apoptosis holds promise as an effective therapeutic strategy for cardiovascular diseases, such as MI and cardiac I/R injury [42] . Cardiomyocyte apoptosis as assessed by TU-NEL assay at the junction of the infarcted area and viable myocardium in the I/R group was significantly attenuated by treatment with IPC. The TUNEL-positive cell ratio in the myocardium of rats pretreated with antagomiR-499 during IPC increased significantly as compared with that observed in the IPC group. This result indicated that miR-499 also played a key role in inhibiting cardiomyocyte apoptosis during IPC.
miR-499 is an anti-apoptotic miRNA. Wang et al. revealed the role of miR-499 in regulating Drp1-mediated mitochondrial fission and cell apoptosis [18] . Additionally, miR-499 also exerts an anti-apoptotic effect on cardiac cells induced by H 2 O 2 . Lower levels of miR-499 in the myocardium are associated with decreased cardiac systolic function during reperfusion as compared with levels of other miRNAs [20] . Furthermore, miR-499 levels in the myocardium are negatively correlated with levels of cardiac troponin complex in the peripheral blood, indicating that myocardial levels of miR-499 might reflect the degree of cardiomyocyte damage [19] . In this study, we showed that miR-499 is involved in IPC cardiac protection in the rat heart with I/R in vivo. Our results suggested that miR-499 protected the heart against ischemic stress by blunting apoptosis induced by I/R partly through its suppressive effect on the expression of the pro-apoptotic gene Pdcd4.
Necrosis is morphologically characterized by myofibrillar contraction bands, swollen and ruptured mitochondria, destruction of cardiomyocyte membranes, microvascular destruction, hemorrhage, and inflammation [2] . Necrosis is thought to result from unregulated and uncoordinated pathophysiological mechanisms [2] . Unlike necrosis, apoptosis is regulated processes with specific underlying signal transduction mechanisms [2] . Apoptosis is an energy-consuming form of cell death characterized by characteristic deoxyribonucleic acid strand breaks that are identified by deoxyribonucleic acid laddering and/or terminal deoxynucleotidyl transferase dUTP nick-end labeling staining [2] . PDCD4 is a critical mediator of apoptosis. Yang et al. demonstrated that PDCD4 is a novel tumor suppressor that interacts with the translation-initiation factors eIF4A and eIF4G to inhibit protein translation [43] . Lin et al. clarified that Pdcd4 is an important target gene of miR-21 associated with anti-apoptotic effects on vascular smooth-muscle cells in response to H 2 O 2 stimulation [44] . In a recent in vitro study, PDCD4 regulated by miR-21 was also a direct target of miR-21 in cardiomyocytes resulting in inhibition of cardiomyocyte injury characterized by apoptosis in cardiac cells exposed to H 2 O 2 via adenovirus-mediated overexpression of PDCD4 [21] . Additionally, the roles associated with Pdcd4 as a target gene of miR-21 and a regulator of miR-21-mediated cardiac cell protection were further verified in cultured cardiac cells and in a cardiac cell I/R model [34] . Moreover, miR-499 inhibited cardiomyocyte apoptosis by suppressing the expression of the pro-apoptotic gene Pdcd4 [20] . Therefore, PDCD4 could constitute an active molecule under disease conditions.
Our results demonstrated that PDCD4 protein levels markedly decreased in rat hearts treated with IPC as compared with those observed in the I/R group in vivo (Fig. 7E, F) . Furthermore, the IPC + antagomiR-499 group showed a significant increase in PDCD4 protein levels as compared with those observed in the IPC + scramble group in vivo (P < 0.05) (Fig. 7E, F) . The abrogation effectiveness of postconditioning's protection by the microR-NA-499 antagonist in almost all parameters was parallel to the knockdown of miR-499 levels inhibited via antagomiR-499. Additionally, the anti-apoptotic effect of miR-499 on cardiomyocytes in vivo and in vitro was attributed, at least in part, to the repression of PDCD4 and intervention using a single molecule might be partly to protect the heart against I/R, which is a process involving multiple pathophysiological components. This may reflect our still incomplete knowledge of the biological mechanism of postconditioning's protection.
These results indicated that PDCD4 was involving in the mechanistic relevance of miR-499-mediated cardiac protection during IPC in vivo. Furthermore, Pdcd4 is validated as an miR-499-target gene a luciferase-reporter assay (Fig. 7H) . Introduction of mutations in the 3′-UTR of Pdcd4 blocked the inhibitory effect of miR-499 on reporter-translation activity. Additionally, previous studies using mouse myocardial I/R injury model showed that knockdown of PDCD4 in vivo attenuated ischemia-induced cardiomyocyte damage by decreasing apoptosis, and overexpression of PDCD4 abolished this effect [21, 45] . Taken together, these studies consistently suggest that miR-499 plays a cardioprotective role in vitro and in vivo and would be a potential therapeutic agent for the treatment of ischemic heart disease by inhibiting apoptosis through PDCD4.
In summary, our data suggested that miR-499 plays an important role in IPC-mediated protective effects against myocardial I/R injury. The mechanical manipulation by IPC of the early phase of reperfusion may reduce the extent of I/R injury. IPC-induced upregulation of endogenous miR-499 is associated with I/R-induced cardiomyocyte apoptosis of the infarct area in the rat heart potentially by targeting PDCD4. Our results indicated that IPC-regulated miR-499 may be a promising therapeutic and preventive target for the treatment of ischemic heart diseases. However, this study had limitations. First, all experiments were performed in rats, and the experimental results may not be directly extrapolated to humans. Therefore, future investigations are warranted to identify the precise mechanisms and confirm our current findings.
